RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)

35.84 UNCHANGED

Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	35.63 (200)
Ask (Size)	35.86 (100)
Prev. Close	35.84
Today's Range	35.84 - 35.84
52wk Range	5.666 - 42.39
Shares Outstanding	34,358,152
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...

Via MarketMinute

RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

November 06, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

Performance

YTD	+174.8%	+174.8%
1 Month	+19.6%	+19.6%
3 Month	+46.6%	+46.6%
6 Month	+268.3%	+268.3%
1 Year	+147.5%	+147.5%

More News

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

November 04, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies

October 27, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock

October 21, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics Announces Proposed Public Offering of Common Stock

October 21, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 20, 2025

Via Benzinga

Rapt Therapeutics, Outperforming 98% Of All Stocks, Skyrockets After Topping Roche ↗

October 20, 2025

Via Investor's Business Daily

These stocks are moving in today's pre-market session ↗

October 20, 2025

Via Chartmill

RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria

October 20, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

October 20, 2025

Via Benzinga

RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)

October 19, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy

September 29, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

August 27, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics Reports Second Quarter 2025 Financial Results

August 07, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

There are notable gap-ups and gap-downs in today's session. ↗

July 15, 2025

Via Chartmill

RAPT Therapeutics Names Two Industry Veterans to its Board of Directors

June 23, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split

June 13, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position ↗

June 05, 2025

Via Stocktwits

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 05, 2025

Via Benzinga

RAPT Therapeutics to Participate in Upcoming Investor Conferences

June 04, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 16, 2025

Via Benzinga

RAPT Therapeutics Reports First Quarter 2025 Financial Results

May 08, 2025

From RAPT Therapeutics, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is RAPT Therapeutics, Inc. - Common Stock publicly traded?

Yes, RAPT Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does RAPT Therapeutics, Inc. - Common Stock trade on?

RAPT Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for RAPT Therapeutics, Inc. - Common Stock?

The ticker symbol for RAPT Therapeutics, Inc. - Common Stock is RAPT on the Nasdaq Stock Market

What is the current price of RAPT Therapeutics, Inc. - Common Stock?

The current price of RAPT Therapeutics, Inc. - Common Stock is 35.84

When was RAPT Therapeutics, Inc. - Common Stock last traded?

The last trade of RAPT Therapeutics, Inc. - Common Stock was at 12/24/25 01:00 PM ET

What is the market capitalization of RAPT Therapeutics, Inc. - Common Stock?

The market capitalization of RAPT Therapeutics, Inc. - Common Stock is 1.23B

How many shares of RAPT Therapeutics, Inc. - Common Stock are outstanding?

RAPT Therapeutics, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.